NCT01378975
- Conditions
- Malignant Melanoma, Melanoma, Neoplasms, +10 more
- Locations
-
- Los Angeles, California, United States
- Aurora, Colorado, United States
- Tampa, Florida, United States
- Boston, Massachusetts, United States
Clinical trial condition
Neuroendocrine Tumors
Explore clinical trials studying Neuroendocrine Tumors. Study availability and eligibility vary by location and protocol.
2,775 public trials
502 recruiting studies
Neuroendocrine Tumors trial results
NCT05534594
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Medullary, +20 more
- Locations
-
- University Medical Centre Groningen Groningen, Provincie Groningen, Netherlands
NCT01351103
- Conditions
- BRAF Mutant Colorectal Cancer, Breast Diseases, Breast Neoplasms, +35 more
- Locations
-
- UCLA School of Medicine Los Angeles, California, United States
- Sidney Kimmel Comprehensive Cancer Center Johns Hopkins Baltimore, Maryland, United States
- Dana Farber Cancer Institute SC-7 Boston, Massachusetts, United States
- University of Michigan Comprehensive Cancer Center Onc Dept. Ann Arbor, Michigan, United States
NCT02836795
- Conditions
- Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, +17 more
- Locations
-
- Beijing Cancer Hospital Beijing, Beijing Municipality, China
NCT02259231
- Conditions
- Melanoma, Metastatic (Stage IV) Melanoma, Neoplasm Metastasis, +15 more
- Locations
-
- Southern Cancer Center Mobile, Alabama, United States
- Highlands Oncology Group Fayetteville, Arkansas, United States
- University of Colorado Cancer Center, Anschutz Cancer Pavilion Aurora, Colorado, United States
- Christiana Hospital Helen F. Graham Cancer Center Newark, Delaware, United States
NCT02331134
- Conditions
- Head and Neck Cancer, Head and Neck Neoplasms, Malignant Melanoma, +12 more
- Locations
-
- University of Colorado Cancer Center Aurora, Colorado, United States
NCT04068896
- Conditions
- Adnexal Diseases, Bladder Cancer, Bronchial Neoplasms, +69 more
- Locations
-
- NGM Clinical Study Site Tucson, Arizona, United States
- NGM Clinical Study Site Los Angeles, California, United States
- NGM Clinical Study Site Los Angeles, California, United States
- NGM Clinical Study Site Sacramento, California, United States
NCT02029729
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +25 more
- Locations
-
- H. Lee Moffitt Cancer Center (NSCLC) Tampa, Florida, United States
Completed
Pembrolizumab (MK-3475) as First-line Therapy for Advanced Merkel Cell Carcinoma (MK-3475-913)
NCT03783078
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Merkel Cell, +15 more
- Locations
-
- Laura and Isaac Perlmutter Cancer Center at NYU Langone Health ( Site 0006) New York, United States
- Icahn School of Medicine at Mount Sinai ( Site 0004) New York, United States
- Melanoma Institute Australia ( Site 0400) North Sydney, New South Wales, Australia
- Calvary Mater Newcastle ( Site 0402) Waratah, New South Wales, Australia
NCT06208124
- Conditions
- Adenocarcinoma, Advanced Solid Tumor (Phase 1), Bronchial Neoplasms, +25 more
- Locations
-
- Honor Health Research Institute Scottsdale, Arizona, United States
- City of Hope Duarte, California, United States
- Sarah Cannon Research Institute Denver, Colorado, United States
- Massachusetts General Hospital Boston, Massachusetts, United States